Sigrid Carlen Veasey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sigrid Carlen Veasey has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Polina Fenik
Univ Penn, Perelman Sch Med, Chronobiol & Sleep Inst, Dept Med, Philadelphia, PA 19104 USA
20 shared publicationsGuanxia Zhan
Department of Medicine, Perelman School of Medicine, University of Pennsylvania Philadelphia , Pennsylvania , USA
14 shared publicationsYan Zhu
Univ Penn, Perelman Sch Med, Chronobiol & Sleep Inst, Dept Med, Philadelphia, PA 19104 USA
12 shared publicationsDomenico Pratico
Center for Sleep and Respiratory Neurobiology, Department of Medicine, and Center for Experimental Therapeutics, Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas
4 shared publicationsJing Zhang
Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China, Center for Sleep and Circadian Neurobiology, Department of Medicine, Institute for Diabetes, Obesity and Metabolism, and Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104
4 shared publicationsLori Panossian
Center for Sleep and Circadian Neurobiology, Department of Medicine
3 shared publications
Latest Publications
- Open Access
- 3 June 2024
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 44 (28)
Norepinephrine Drives Sleep Fragmentation Activation of Asparagine Endopeptidase, Locus Ceruleus Degeneration, and Hippocampal Amyloid-β42Accumulation
Chronic sleep disruption (CSD), from insufficient or fragmented sleep and is an important risk factor for Alzheimer's disease (AD). Underlying mechanisms are not understood. CSD in mice results in degeneration of locus ceruleus neurons (LCn) and CA1 hippocampal neurons and increases hippocampal amyloid-β42(Aβ42), entorhinal cortex (EC) tau phosphorylation (p-tau), and glial reactivity. LCn injury is increasingly implicated in AD pathogenesis. CSD increases NE turnover in LCn, and LCn norepinephrine (NE) metabolism activates asparagine endopeptidase (AEP), an enzyme known to cleave amyloid precursor protein (APP) and tau into neurotoxic fragments. We hypothesized that CSD would activate LCn AEP in an NE-dependent manner to induce LCn and hippocampal injury. Here, we studied LCn, hippocampal, and EC responses to CSD in mice deficient in NE [dopamine β-hydroxylase (Dbh)−/−] and control male and female mice, using a model of chronic fragmentation of sleep (CFS). Sleep was equally fragmented inDbh−/−and control male and female mice, yet onlyDbh−/−mice conferred resistance to CFS loss of LCn, LCn p-tau, and LCn AEP upregulation and activation as evidenced by an increase in AEP-cleaved APP and tau fragments. Absence of NE also prevented a CFS increase in hippocampal AEP-APP and Aβ42but did not prevent CFS-increased AEP-tau and p-tau in the EC. Collectively, this work demonstrates AEP activation by CFS, establishes key roles for NE in both CFS degeneration of LCn neurons and CFS promotion of forebrain Aβ accumulation, and, thereby, identifies a key molecular link between CSD and specific AD neural injuries.
- 3 June 2024
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 44 (28)
Open AccessNorepinephrine Drives Sleep Fragmentation Activation of Asparagine Endopeptidase, Locus Ceruleus Degeneration, and Hippocampal Amyloid-β42Accumulation
Chronic sleep disruption (CSD), from insufficient or fragmented sleep and is an important risk factor for Alzheimer's disease (AD). Underlying mechanisms are not understood. CSD in mice results in degeneration of locus ceruleus neurons (LCn) and CA1 hippocampal neurons and increases hippocampal amyloid-β42(Aβ42), entorhinal cortex (EC) tau phosphorylation (p-tau), and glial reactivity. LCn injury is increasingly implicated in AD pathogenesis. CSD increases NE turnover in LCn, and LCn norepinephrine (NE) metabolism activates asparagine endopeptidase (AEP), an enzyme known to cleave amyloid precursor protein (APP) and tau into neurotoxic fragments. We hypothesized that CSD would activate LCn AEP in an NE-dependent manner to induce LCn and hippocampal injury. Here, we studied LCn, hippocampal, and EC responses to CSD in mice deficient in NE [dopamine β-hydroxylase (Dbh)−/−] and control male and female mice, using a model of chronic fragmentation of sleep (CFS). Sleep was equally fragmented inDbh−/−and control male and female mice, yet onlyDbh−/−mice conferred resistance to CFS loss of LCn, LCn p-tau, and LCn AEP upregulation and activation as evidenced by an increase in AEP-cleaved APP and tau fragments. Absence of NE also prevented a CFS increase in hippocampal AEP-APP and Aβ42but did not prevent CFS-increased AEP-tau and p-tau in the EC. Collectively, this work demonstrates AEP activation by CFS, establishes key roles for NE in both CFS degeneration of LCn neurons and CFS promotion of forebrain Aβ accumulation, and, thereby, identifies a key molecular link between CSD and specific AD neural injuries.
- Open Access
- 6 October 2022
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 14, 1025402
Hypocretin/orexin influences chronic sleep disruption injury in the hippocampus
Chronic sleep disruption is a risk factor for Alzheimer’s disease (AD), yet mechanisms by which sleep disturbances might promote or exacerbate AD are not understood. Short-term sleep loss acutely increases hippocampal amyloid β (Aβ) in wild type (WT) mice and long-term sleep loss increases amyloid plaque in AD transgenic mouse models. Both effects can be influenced by the wake-promoting neuropeptide, hypocretin (HCRT), but whether HCRT influences amyloid accumulation independent of sleep and wake timing modulation remains unclear. Here, we induced chronic fragmentation of sleep (CFS) in WT and HCRT-deficient mice to elicit similar arousal indices, sleep bout lengths and sleep bout numbers in both genotypes. We then examined the roles of HCRT in CFS-induced hippocampal Aβ accumulation and injury. CFS in WT mice resulted in increased Aβ42 in the hippocampus along with loss of cholinergic projections and loss of locus coeruleus neurons. Mice with HCRT deficiency conferred resistance to CFS Aβ42 accumulation and loss of cholinergic projections in the hippocampus yet evidenced similar CFS-induced loss of locus coeruleus neurons. Collectively, the findings demonstrate specific roles for orexin in sleep disruption hippocampal injury.Significance statement: Chronic fragmentation of sleep (CFS) occurs in common conditions, including sleep apnea syndromes and chronic pain disorders, yet CFS can induce neural injury. Our results demonstrate that under conditions of sleep fragmentation, hypocretin/orexin is essential for the accumulation of amyloid-β and loss of cholinergic projections in the hippocampus observed in response to CFS yet does not influence locus coeruleus neuron response to CFS.
- 6 October 2022
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 14, 1025402
Open AccessHypocretin/orexin influences chronic sleep disruption injury in the hippocampus
Chronic sleep disruption is a risk factor for Alzheimer’s disease (AD), yet mechanisms by which sleep disturbances might promote or exacerbate AD are not understood. Short-term sleep loss acutely increases hippocampal amyloid β (Aβ) in wild type (WT) mice and long-term sleep loss increases amyloid plaque in AD transgenic mouse models. Both effects can be influenced by the wake-promoting neuropeptide, hypocretin (HCRT), but whether HCRT influences amyloid accumulation independent of sleep and wake timing modulation remains unclear. Here, we induced chronic fragmentation of sleep (CFS) in WT and HCRT-deficient mice to elicit similar arousal indices, sleep bout lengths and sleep bout numbers in both genotypes. We then examined the roles of HCRT in CFS-induced hippocampal Aβ accumulation and injury. CFS in WT mice resulted in increased Aβ42 in the hippocampus along with loss of cholinergic projections and loss of locus coeruleus neurons. Mice with HCRT deficiency conferred resistance to CFS Aβ42 accumulation and loss of cholinergic projections in the hippocampus yet evidenced similar CFS-induced loss of locus coeruleus neurons. Collectively, the findings demonstrate specific roles for orexin in sleep disruption hippocampal injury.Significance statement: Chronic fragmentation of sleep (CFS) occurs in common conditions, including sleep apnea syndromes and chronic pain disorders, yet CFS can induce neural injury. Our results demonstrate that under conditions of sleep fragmentation, hypocretin/orexin is essential for the accumulation of amyloid-β and loss of cholinergic projections in the hippocampus observed in response to CFS yet does not influence locus coeruleus neuron response to CFS.
- 23 August 2022
- Published by Springer Nature
- p. 209-226
Neural Injury in Models of Intermittent Hypoxia
- Open Access
- 26 March 2021
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 44 (8)
Late-in-life neurodegeneration after chronic sleep loss in young adult mice
Chronic short sleep (CSS) is prevalent in modern societies and has been proposed as a risk factor for Alzheimer’s disease (AD). In support, short-term sleep loss acutely increases levels of amyloid β (Aβ) and tau in wild type (WT) mice and humans, and sleep disturbances predict cognitive decline in older adults. We have shown that CSS induces injury to and loss of locus coeruleus neurons (LCn), neurons with heightened susceptibility in AD. Yet whether CSS during young adulthood drives lasting Aβ and/or tau changes and/or neural injury later in life in the absence of genetic risk for AD has not been established. Here, we examined the impact of CSS exposure in young adult WT mice on late-in-life Aβ and tau changes and neural responses in two AD-vulnerable neuronal groups, LCn and hippocampal CA1 neurons. Twelve months following CSS exposure, CSS-exposed mice evidenced reductions in CA1 neuron counts and volume, spatial memory deficits, CA1 glial activation, and loss of LCn. Aβ 42 and hyperphosphorylated tau were increased in the CA1; however, amyloid plaques and tau tangles were not observed. Collectively the findings demonstrate that CSS exposure in the young adult mouse imparts late-in-life neurodegeneration and persistent derangements in amyloid and tau homeostasis. These findings occur in the absence of a genetic predisposition to neurodegeneration and demonstrate for the first time that CSS can induce lasting, significant neural injury consistent with some, but not all, features of late-onset AD.
- 26 March 2021
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 44 (8)
Open AccessLate-in-life neurodegeneration after chronic sleep loss in young adult mice
Chronic short sleep (CSS) is prevalent in modern societies and has been proposed as a risk factor for Alzheimer’s disease (AD). In support, short-term sleep loss acutely increases levels of amyloid β (Aβ) and tau in wild type (WT) mice and humans, and sleep disturbances predict cognitive decline in older adults. We have shown that CSS induces injury to and loss of locus coeruleus neurons (LCn), neurons with heightened susceptibility in AD. Yet whether CSS during young adulthood drives lasting Aβ and/or tau changes and/or neural injury later in life in the absence of genetic risk for AD has not been established. Here, we examined the impact of CSS exposure in young adult WT mice on late-in-life Aβ and tau changes and neural responses in two AD-vulnerable neuronal groups, LCn and hippocampal CA1 neurons. Twelve months following CSS exposure, CSS-exposed mice evidenced reductions in CA1 neuron counts and volume, spatial memory deficits, CA1 glial activation, and loss of LCn. Aβ 42 and hyperphosphorylated tau were increased in the CA1; however, amyloid plaques and tau tangles were not observed. Collectively the findings demonstrate that CSS exposure in the young adult mouse imparts late-in-life neurodegeneration and persistent derangements in amyloid and tau homeostasis. These findings occur in the absence of a genetic predisposition to neurodegeneration and demonstrate for the first time that CSS can induce lasting, significant neural injury consistent with some, but not all, features of late-onset AD.
- Open Access
- 1 June 2020
- Published by Elsevier in Neurobiology of Disease
- Vol. 139, 104820
Impact of sleep disturbances on neurodegeneration: Insight from studies in animal models
- 1 June 2020
- Published by Elsevier in Neurobiology of Disease
- Vol. 139, 104820
Open AccessImpact of sleep disturbances on neurodegeneration: Insight from studies in animal models
- Open Access
- 15 October 2018
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 38 (48) , 10255-10270
Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice
Brainstem locus ceruleus neurons (LCn) are among the first neurons across the lifespan to evidence tau pathology, and LCn are implicated in tau propagation throughout the cortices. Yet, events influencing LCn tau are poorly understood. Activated persistently across wakefulness, LCn experience significant metabolic stress in response to chronic short sleep (CSS). Here we explored whether CSS influences LCn tau and the biochemical, neuroanatomical, and/or behavioral progression of tauopathy in male and female P301S mice. CSS in early adult life advanced the temporal progression of neurobehavioral impairments and resulted in a lasting increase in soluble tau oligomers. Intriguingly, CSS resulted in an early increase in AT8 and MC1 tau pathology in the LC. Over time tau pathology, including tangles, was evident in forebrain tau-vulnerable regions. Sustained microglial and astrocytic activation was observed as well. Remarkably, CSS resulted in significant loss of neurons in the two regions examined: the basolateral amygdala and LC. A second, distinct form of chronic sleep disruption, fragmentation of sleep, during early adult life also increased tau deposition and imparted early neurobehavioral impairment. Collectively, the findings demonstrate that early life sleep disruption has important lasting effects on the temporal progression in P301S mice, influencing tau pathology and hastening neurodegeneration, neuroinflammation, and neurobehavioral impairments.SIGNIFICANCE STATEMENTChronic short sleep (CSS) is pervasive in modern society. Here, we found that early life CSS influences behavioral, biochemical, and neuroanatomic aspects of the temporal progression of tauopathy in a mouse model of the P301S tau mutation. Specifically, CSS hastened the onset of motor impairment and resulted in a greater loss of neurons in both the locus ceruleus and basolateral/lateral amygdala. Importantly, despite a protracted recovery opportunity after CSS, mice evidenced a sustained increase in pathogenic tau oligomers, and increased pathogenic tau in the locus ceruleus and limbic system nuclei. These findings unveil early life sleep habits as an important determinant in the progression of tauopathy.
- 15 October 2018
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 38 (48) , 10255-10270
Open AccessChronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice
Brainstem locus ceruleus neurons (LCn) are among the first neurons across the lifespan to evidence tau pathology, and LCn are implicated in tau propagation throughout the cortices. Yet, events influencing LCn tau are poorly understood. Activated persistently across wakefulness, LCn experience significant metabolic stress in response to chronic short sleep (CSS). Here we explored whether CSS influences LCn tau and the biochemical, neuroanatomical, and/or behavioral progression of tauopathy in male and female P301S mice. CSS in early adult life advanced the temporal progression of neurobehavioral impairments and resulted in a lasting increase in soluble tau oligomers. Intriguingly, CSS resulted in an early increase in AT8 and MC1 tau pathology in the LC. Over time tau pathology, including tangles, was evident in forebrain tau-vulnerable regions. Sustained microglial and astrocytic activation was observed as well. Remarkably, CSS resulted in significant loss of neurons in the two regions examined: the basolateral amygdala and LC. A second, distinct form of chronic sleep disruption, fragmentation of sleep, during early adult life also increased tau deposition and imparted early neurobehavioral impairment. Collectively, the findings demonstrate that early life sleep disruption has important lasting effects on the temporal progression in P301S mice, influencing tau pathology and hastening neurodegeneration, neuroinflammation, and neurobehavioral impairments.SIGNIFICANCE STATEMENTChronic short sleep (CSS) is pervasive in modern society. Here, we found that early life CSS influences behavioral, biochemical, and neuroanatomic aspects of the temporal progression of tauopathy in a mouse model of the P301S tau mutation. Specifically, CSS hastened the onset of motor impairment and resulted in a greater loss of neurons in both the locus ceruleus and basolateral/lateral amygdala. Importantly, despite a protracted recovery opportunity after CSS, mice evidenced a sustained increase in pathogenic tau oligomers, and increased pathogenic tau in the locus ceruleus and limbic system nuclei. These findings unveil early life sleep habits as an important determinant in the progression of tauopathy.
- 1 January 2018
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 41 (1)
Obstructive sleep apnea drug therapy: apnea–hypopnea index leaves us high and dry
The past four decades of sleep apnea research have yielded tremendous insight into the pathophysiology of obstructive sleep apnea (OSA). Elegant research has substantiated that sleep state–dependent upper airway collapse obstructs ventilation, inducing intermittent reductions in oxygen, coincidental with increases in carbon dioxide, autonomic instability, and, typically, a brief arousal.1 We understand that upper airway collapse occurs, at least in part, because of reduced activity of upper airway dilator muscles in sleep, and we now understand more fully some of the sleep state–dependent alterations in neurotransmitters and modulators at the relevant motoneurons.2 Based on these advances, one would have anticipated 10–20 years ago that by now we would have one or more successful pharmacotherapies for OSA. The need for a pharmacotherapy is readily...
- 1 January 2018
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 41 (1)
Obstructive sleep apnea drug therapy: apnea–hypopnea index leaves us high and dry
The past four decades of sleep apnea research have yielded tremendous insight into the pathophysiology of obstructive sleep apnea (OSA). Elegant research has substantiated that sleep state–dependent upper airway collapse obstructs ventilation, inducing intermittent reductions in oxygen, coincidental with increases in carbon dioxide, autonomic instability, and, typically, a brief arousal.1 We understand that upper airway collapse occurs, at least in part, because of reduced activity of upper airway dilator muscles in sleep, and we now understand more fully some of the sleep state–dependent alterations in neurotransmitters and modulators at the relevant motoneurons.2 Based on these advances, one would have anticipated 10–20 years ago that by now we would have one or more successful pharmacotherapies for OSA. The need for a pharmacotherapy is readily...
- Open Access
- 31 May 2017
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 8, 235
Neural Consequences of Chronic Short Sleep: Reversible or Lasting?
Approximately one third of adolescents and adults in developed countries regularly experience insufficient sleep across the school and/or work week interspersed with weekend catch up sleep. This common practice of weekend recovery sleep reduces subjective sleepiness, yet recent studies demonstrate that one weekend of recovery sleep may not be sufficient in all persons to fully reverse all neurobehavioral impairments observed with chronic sleep loss, particularly vigilance. Moreover, recent studies in animal models demonstrate persistent injury to and loss of specific neuron types in response to chronic short sleep with lasting effects on sleep/wake patterns. Here we provide a comprehensive review of the effects of chronic sleep disruption on neurobehavioral performance and injury to neurons, astrocytes, microglia and oligodendrocytes and discuss what is known and what is not yet established for reversibility of neural injury. Recent neurobehavioral findings in humans are integrated with animal model research examining long-term consequences of sleep loss on neurobehavioral performance, brain development, neurogenesis, neurodegeneration, and connectivity. What is known of the molecular mechanisms underlying sleep loss neural injury will be described and future directions for work in this emerging area of sleep neurobiology will be discussed.While it is now clear that recovery of vigilance following short sleep requires longer than one weekend, less is know of the impact of chronic short sleep on cognitive function, mood and brain health long term. From work performed in animal models chronic short sleep in the young adult and short term sleep loss in critical developmental windows can have lasting detrimental effects on neurobehavioral performance.
- 31 May 2017
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 8, 235
Open AccessNeural Consequences of Chronic Short Sleep: Reversible or Lasting?
Approximately one third of adolescents and adults in developed countries regularly experience insufficient sleep across the school and/or work week interspersed with weekend catch up sleep. This common practice of weekend recovery sleep reduces subjective sleepiness, yet recent studies demonstrate that one weekend of recovery sleep may not be sufficient in all persons to fully reverse all neurobehavioral impairments observed with chronic sleep loss, particularly vigilance. Moreover, recent studies in animal models demonstrate persistent injury to and loss of specific neuron types in response to chronic short sleep with lasting effects on sleep/wake patterns. Here we provide a comprehensive review of the effects of chronic sleep disruption on neurobehavioral performance and injury to neurons, astrocytes, microglia and oligodendrocytes and discuss what is known and what is not yet established for reversibility of neural injury. Recent neurobehavioral findings in humans are integrated with animal model research examining long-term consequences of sleep loss on neurobehavioral performance, brain development, neurogenesis, neurodegeneration, and connectivity. What is known of the molecular mechanisms underlying sleep loss neural injury will be described and future directions for work in this emerging area of sleep neurobiology will be discussed.While it is now clear that recovery of vigilance following short sleep requires longer than one weekend, less is know of the impact of chronic short sleep on cognitive function, mood and brain health long term. From work performed in animal models chronic short sleep in the young adult and short term sleep loss in critical developmental windows can have lasting detrimental effects on neurobehavioral performance.
- Open Access
- 10 April 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (5) , 1889-1904
Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome–like phenotypes
Mutations in the X-linked gene encoding methyl-CpG–binding protein 2 (MeCP2) cause Rett syndrome (RTT), a neurological disorder affecting cognitive development, respiration, and motor function. Genetic restoration of MeCP2 expression reverses RTT-like phenotypes in mice, highlighting the need to search for therapeutic approaches. Here, we have developed knockin mice recapitulating the most common RTT-associated missense mutation, MeCP2 T158M. We found that the T158M mutation impaired MECP2 binding to methylated DNA and destabilized MeCP2 protein in an age-dependent manner, leading to the development of RTT-like phenotypes in these mice. Genetic elevation of MeCP2 T158M expression ameliorated multiple RTT-like features, including motor dysfunction and breathing irregularities, in both male and female mice. These improvements were accompanied by increased binding of MeCP2 T158M to DNA. Further, we found that the ubiquitin/proteasome pathway was responsible for MeCP2 T158M degradation and that proteasome inhibition increased MeCP2 T158M levels. Together, these findings demonstrate that increasing MeCP2 T158M protein expression is sufficient to mitigate RTT-like phenotypes and support the targeting of MeCP2 T158M expression or stability as an alternative therapeutic approach.
- 10 April 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (5) , 1889-1904
Open AccessElevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome–like phenotypes
Mutations in the X-linked gene encoding methyl-CpG–binding protein 2 (MeCP2) cause Rett syndrome (RTT), a neurological disorder affecting cognitive development, respiration, and motor function. Genetic restoration of MeCP2 expression reverses RTT-like phenotypes in mice, highlighting the need to search for therapeutic approaches. Here, we have developed knockin mice recapitulating the most common RTT-associated missense mutation, MeCP2 T158M. We found that the T158M mutation impaired MECP2 binding to methylated DNA and destabilized MeCP2 protein in an age-dependent manner, leading to the development of RTT-like phenotypes in these mice. Genetic elevation of MeCP2 T158M expression ameliorated multiple RTT-like features, including motor dysfunction and breathing irregularities, in both male and female mice. These improvements were accompanied by increased binding of MeCP2 T158M to DNA. Further, we found that the ubiquitin/proteasome pathway was responsible for MeCP2 T158M degradation and that proteasome inhibition increased MeCP2 T158M levels. Together, these findings demonstrate that increasing MeCP2 T158M protein expression is sufficient to mitigate RTT-like phenotypes and support the targeting of MeCP2 T158M expression or stability as an alternative therapeutic approach.
- Open Access
- 1 August 2016
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 39 (8) , 1601-1611
Intermittent Short Sleep Results in Lasting Sleep Wake Disturbances and Degeneration of Locus Coeruleus and Orexinergic Neurons
Study Objectives:. Intermittent short sleep (ISS) is pervasive among students and workers in modern societies, yet the lasting consequences of repeated
- 1 August 2016
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 39 (8) , 1601-1611
Open AccessIntermittent Short Sleep Results in Lasting Sleep Wake Disturbances and Degeneration of Locus Coeruleus and Orexinergic Neurons
Study Objectives:. Intermittent short sleep (ISS) is pervasive among students and workers in modern societies, yet the lasting consequences of repeated